Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Targeted treatments have emerged as a safer and more effective option for eczema patients, but high costs remain a barrier.

KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...

Tom Nolan reviews this week’s research Post-thrombotic syndrome affects up to half of people within two years of a lower leg ...

TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist ...

The study1 by Emma Guttman-Yassky and colleagues represents an important and innovative contribution to the evolving treatment landscape of moderate-to-severe atopic dermatitis, particularly by ...

After a study revealed higher cancer and other risks with a JAK inhibitor in patients with rheumatoid arthritis, further ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose husband found a solution for seborrheic dermatitis on his scalp.

Studies suggest a way to call off the so-called atopic march ...

While carpet beetles don’t harm humans or pets directly, their larvae can cause mild skin irritation or allergic reactions.

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

Thyme is an herb in the mint family and a staple ingredient in cooking. It may also offer a range of health benefits, ...